Highlights

Early career researchers zoom in on an important drug target

Early career researchers zoom in on an important drug target

An estimated 1.3 million people die from tuberculosis (TB) each year, and new drugs are desperately needed, especially as res...

read the full story

Chemistry, bio and immunology combine to target immune receptor

Chemistry, bio and immunology combine to target immune receptor

A Maurice Wilkins Centre collaboration across several scientific disciplines has led to a patent for a new immunotherapy drug...

read the full story

Re-thinking the causes of rheumatic fever

Re-thinking the causes of rheumatic fever

Researchers and health professionals are re-thinking the causes of rheumatic fever after studies by Maurice Wilkins Centre in...

read the full story

The tumour-promoting activities of a famous protein

The tumour-promoting activities of a famous protein

Developing new cancer therapies and a more reliable test for prostate cancer are just some of the potential outcomes of Mauri...

read the full story

New insight into an established diabetes target

New insight into an established diabetes target

Facilitating the development of better medicines for diabetes, obesity and cardiovascular disease is a key driver behind some...

read the full story

Cells get increasing coverage

Cells get increasing coverage

Human cells have always been important in Maurice Wilkins Centre research, but new developments open up new ground for both r...

read the full story

Using 'molecular superglue' to build protein trees

Using 'molecular superglue' to build protein trees

Biological batteries, new vaccines and more cost-effective pharmaceuticals are just some of the potential benefits of Maurice...

read the full story

Newly funded research highlights MWC collaborations

Newly funded research highlights MWC collaborations

A five-year research programme aims to develop nontoxic vaccine technologies to complement existing cancer immunotherapies.

read the full story

Home-grown research attracts high investor interest

Home-grown research attracts high investor interest

Home-grown, high-tech health research from the Maurice Wilkins Centre has attracted support from local and international inve...

read the full story